Showing results (1-10 of 461) with videos related to
Sort By:
Pageof 47
Bulletin Du Cancer|September 26, 2020
[Predictable toxicities with futures immunotherapies or combinations]Alice Mogenet, Pascale Tomasini, Laurent Greillier, et al.Pharmacogenomics and Personalized Medicine|August 25, 2021
The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung CancerAlice Mogenet, Laurent Greillier, Pascale TomasiniBulletin Du Cancer|March 28, 2025
[Recommendations for the management of oligometatic NSCLC]Alice Mogenet, Laurent Greillier, Pascale TomasiniTherapeutic Advances in Respiratory Disease|June 25, 2016
Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experienceLaurent Greillier, Pascale Tomasini, Fabrice BarlesiExpert Opinion on Biological Therapy|June 9, 2015
Necitumumab for non-small cell lung cancerLaurent Greillier, Pascale Tomasini, Fabrice BarlesiTranslational Lung Cancer Research|December 4, 2018
The clinical utility of tumor mutational burden in non-small cell lung cancerLaurent Greillier, Pascale Tomasini, Fabrice BarlesiEuropean Respiratory Review : an Official Journal of the European Respiratory Society|November 17, 2017
Personalised medicine for nonsmall cell lung cancerCéline Mascaux, Pascale Tomasini, Laurent Greillier, et al.Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.Expert Review of Anticancer Therapy|March 13, 2013
The place of pemetrexed in the management of non-small-cell lung cancer patientsPascale Tomasini, Laurent Greillier, Nataliya Khobta, et al.Therapeutic Advances in Medical Oncology|March 17, 2012
Ipilimumab: its potential in non-small cell lung cancerPascale Tomasini, Nataliya Khobta, Laurent Greillier, et al.Pageof 47